Kounis Syndrome is a rare heart problem. It happens when someone has a heart attack or chest pain, and it's triggered by an allergic reaction. This reaction can be caused by certain medicines, foods, or insect stings. It's like an allergic reaction causing a heart issue.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Kounis syndrome is a heart attack or episode of unstable angina (chest pain from reduced blood flow to the heart) that is set off by an allergic reaction. It is also called allergic angina or allergic myocardial infarction. During a strong allergic reaction, immune cells release chemicals such as histamine. In Kounis syndrome, those chemicals also affect the coronary arteries that supply the heart muscle, either by making them clamp down in spasm or by helping a clot form. Doctors describe several types. In the most common, type I, the arteries are largely free of blockages and the problem is a temporary spasm. In type II, the allergic reaction destabilizes an existing cholesterol plaque and a clot forms, as in a typical heart attack. Types III and IV affect people who already have a coronary stent or bypass graft, where a clot forms in the stent or graft. Kounis syndrome is considered uncommon but underrecognized, partly because its symptoms overlap with both allergy and ordinary heart disease.
Almost anything that can cause an allergic reaction can trigger Kounis syndrome. Medicines are the most commonly reported cause, especially antibiotics such as amoxicillin and other penicillins and cephalosporins. Other reported triggers include pain relievers in the nonsteroidal anti-inflammatory (NSAID) family, contrast dye used for scans and heart procedures, some chemotherapy drugs, bee and wasp stings, other bites and stings, and foods such as shellfish, fish, nuts and some fruits. Latex and certain chemical exposures have also been implicated. People with a known allergy face a risk if re-exposed to the same trigger, but most people who develop Kounis syndrome had no recorded allergy beforehand, and some reactions occur on a first exposure. That makes the syndrome hard to predict. It can occur at any age, from childhood to old age, and reported cases are more often men. Existing coronary artery disease, or a stent or bypass graft, sets the stage for the more serious clot-forming types.
Kounis syndrome is diagnosed when signs of a heart attack or reduced blood flow to the heart appear together with an allergic reaction, soon after an exposure. Chest pain is the most common symptom, often with shortness of breath, palpitations, sweating or low blood pressure. Hives, flushing, itching or swelling are common clues, but they can be mild or absent altogether, so the heart symptoms may be the main sign. In the emergency setting, doctors use an electrocardiogram (ECG, a recording of the heart's electrical activity) and blood tests for troponin, a protein released when heart muscle is injured. An ultrasound of the heart (echocardiogram) shows whether part of the heart muscle is moving poorly. Coronary angiography, an X-ray of the heart arteries using dye through a thin tube, shows whether a vessel is blocked or in spasm and is often normal in type I. A blood test for tryptase, a chemical released by allergy cells, supports the allergic part of the diagnosis when drawn early, but a normal result does not rule it out. There is no single test for Kounis syndrome; the diagnosis comes from putting these findings together with the timing of the exposure.
Treatment deals with the allergic reaction and the heart problem at the same time, usually in an emergency department or cardiac unit. There are no dedicated treatment guidelines, so care draws on standard anaphylaxis and heart attack treatment, adjusted case by case. The first step is to stop exposure to the trigger, such as halting an infusion. For the allergic reaction, doctors commonly give corticosteroids and antihistamines. Epinephrine (adrenaline), the emergency medicine for anaphylaxis, can in theory worsen artery spasm, but it remains the essential treatment for a life-threatening allergic reaction and should not be withheld when one is present. For the heart, medicines that relax the arteries, such as nitroglycerin, are often used for spasm when blood pressure allows. When a clot is blocking an artery, stent or graft, treatment follows heart attack care, with blood-thinning medicines and often angioplasty, in which a balloon reopens the artery and a stent may be placed. Doctors also avoid certain usual heart attack medicines, such as morphine for pain, that can worsen an allergic reaction.
Most people recover fully, particularly those with type I, in which the spasm passes and the heart muscle usually returns to normal without lasting damage. The episode can still be serious: some people develop dangerous heart rhythms, very low blood pressure or cardiac arrest, and the outlook is less favorable with clot-forming types, especially in people with stents. After the acute event, care typically includes a short hospital stay with heart monitoring. The most important long-term step is identifying the trigger and avoiding it, because repeat episodes are usually caused by re-exposure to the same substance. That often means a referral to an allergist, an updated allergy list in medical records, and telling every clinician, pharmacist and imaging team about the reaction before new medicines, contrast dye or procedures. There is no evidence that taking heart medicines indefinitely prevents another episode of type I. People with underlying coronary artery disease continue the usual follow-up and treatment for that condition.
Call 911 for chest pain or tightness, trouble breathing, throat tightness, or fainting during or after an allergic reaction or a sting, new medicine or other exposure; if you have an epinephrine auto-injector, use it right away. Arrange follow-up with your doctor or an allergist after any episode to identify the trigger and plan how to avoid it, and before any planned procedure that uses contrast dye or medicines linked to a past reaction.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Kounis Syndrome is like, what's helped you, or ask the community a question.